India's Sun Pharma Advanced Research falls after Q2 loss widens
** Shares of Sun Pharma Advanced Research Co SPRC.NS fall
4.7% to 205.80 rupees
** The clinical-stage biopharmaceutical co's Q2 consol loss
widened to 1.07 bln rupees ($12.7 mln) vs loss of 864.2 mln
rupees a year ago, revenue down 39% Y/Y
** SPRC set to snap five-session winning streak
** Trading vols 1.9x the 30-day average
** Stock down ~28% YTD
($1 = 84.1125 Indian rupees)
(Reporting by Vijay Malkar)
((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees